ClinConnect ClinConnect Logo
Search / Trial NCT03062085

Shanghai High Myopia Study

Launched by SHANGHAI HIGH MYOPIA STUDY GROUP · Feb 22, 2017

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The Shanghai High Myopia Study is looking into how well people with high myopia (a condition where the eye is too long, making it hard to see far away) do after having cataract surgery. Researchers want to understand not only the results of the surgery but also what genetic and environmental factors might lead to cataracts in patients with high myopia. This study includes a large group of participants to gather comprehensive data on this topic.

If you're considering joining this trial, you need to have a clinical diagnosis of cataract and be able to participate in eye examinations. Unfortunately, individuals with mental illness or disabilities that affect their ability to cooperate with the study will not be eligible. Participants can expect to contribute to important research while receiving care related to their cataracts. The study is currently recruiting people aged between 20 and 70, so if you or a family member fit this description, you might want to learn more about participating.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical diagnosis of cataract
  • Must be able to cooperate with the ophthalmic examination
  • Exclusion Criteria:
  • Clinical diagnosis of mental illness
  • Mentally disabled

About Shanghai High Myopia Study Group

The Shanghai High Myopia Study Group is a collaborative research consortium dedicated to investigating the epidemiology, etiology, and management of high myopia, a significant public health concern in urban populations. Comprising a multidisciplinary team of ophthalmologists, optometrists, and public health experts, the group conducts innovative clinical trials and observational studies aimed at understanding the progression of myopia and developing effective interventions. By leveraging advanced imaging technologies and longitudinal data collection, the group strives to enhance clinical practices and inform public health strategies to mitigate the impact of high myopia on visual health in the community.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Trial Officials

Yi Lu, M.D.

Study Chair

Eye and ENT Hospital of Fudan University

Xiangjia Zhu, M.D.

Study Director

Eye and ENT Hospital of Fudan University

Keke Zhang, M.D.

Principal Investigator

Eye and ENT Hospital of Fudan University

Wenwen He, M.D.

Principal Investigator

Eye and ENT Hospital of Fudan University

Yu Du, B.S.

Principal Investigator

Eye and ENT Hospital of Fudan University

Yinglei Zhang, M.D.

Principal Investigator

Eye and ENT Hospital of Fudan University

Zhennan Zhao, Ph.D.

Principal Investigator

Eye and ENT Hospital of Fudan University

Ruiqi Chang, B.S.

Principal Investigator

Eye and ENT Hospital of Fudan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials